Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 extension study of dutogliptin vs sitagliptin in type 2 diabetes mellitus on metformin background
2009-012663-34Phase 3Terminated
- Sponsor
- Phenomix Sciences
- Start
- Feb 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dutogliptin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Phenomix Sciences. Primary endpoint: Primary safety endpoint. Started Feb 2010; status: terminated.
02
Drugs
dutogliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2009-012663-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012663-34.